Medpace Holdings (MEDP) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
20 figures withheld by our checks. Each blank figure names its reason.
37.7mn → 29.5mn diluted shares since FY21. Part of EPS growth is the shrinking denominator. Watch net income too.
steady at 1.2% of revenue (−14.2% YoY).
$917.4M returned vs $681.9M of FCF in FY25. The gap comes off the balance sheet (see net cash).
18¢ of every revenue dollar becomes profit.
Net margin 17.8% is more than double the sector median. This filer reports no gross profit line, so that margin is not drawn.
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 2,838.4 | 2,530.2 | 2,109.1 | 1,885.8 | 1,460.0 | 1,142.4 | ▲20.0% | +22.0% |
Cost of revenue | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — |
Gross profit | —A | —A | —A | —A | —A | —A | — | — |
Selling, general & admin | 192.7 | 197.6 | 180.2 | 161.4 | 131.4 | 108.4 | ▲9.6% | +16.2% |
Total operating expenses | 2,231.2 | 1,995.3 | 1,662.2 | 1,549.0 | 1,181.3 | 943.8 | ▲20.0% | +20.6% |
Operating incomefeeds ROC rank | 607.1 | 534.9 | 446.9 | 336.8 | 278.7 | 198.6 | ▲19.7% | +28.1% |
Other income, net | 19.9 | 7.4 | 29.1 | −1.1 | 4.2 | 3.2 | — | — |
Pretax income | 627.0 | 542.4 | 475.9 | 335.7 | 282.9 | 201.9 | ▲14.0% | +28.0% |
Income tax | 109.2 | 91.3 | 71.5 | 52.9 | 37.5 | 20.0 | ▲27.6% | +46.1% |
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings | 517.8 | 451.1 | 404.4 | 282.8 | 245.4 | 181.8 | ▲11.6% | +25.5% |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | 18.02 | 15.28 | 12.63 | 8.88 | 7.28 | 4.81 | ▲21.0% | +33.5% |
Diluted shares (mn) | 28.37 | 29.53 | 32.01 | 31.84 | 33.67 | 37.70 | ▼7.8% | −5.9% |
| Margins | ||||||||
Gross margin | —A | —A | —A | —A | —A | —A | — | — |
Operating margin | 21.4% | 21.1% | 21.2% | 17.9% | 19.1% | 17.4% | ▼0.0pp | +3.8pp |
Net margin82nd pct in Healthcare | 18.2% | 17.8% | 19.2% | 15.0% | 16.8% | 15.9% | ▼1.3pp | +1.9pp |
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Medpace Holdings' revenue last fiscal year?
Medpace Holdings reported revenue of $2,530.2M in fiscal 2025, up 20.0% from fiscal 2024.
What was Medpace Holdings' net income?
Medpace Holdings reported net income of $451.1M in fiscal 2025, a net margin of 17.8%.

